News

Moral distress in physicians: New study measures prevalence, offers interventions

Almost two in five physicians suffered moral distress in the two weeks leading up to their being asked about it by researchers. That was a markedly larger slice than the team observed in the general U.S. working population.

Cryoablation treatment for inoperable non-small cell lung cancer

Cryoablation outshines radiation therapy, surgery for treating certain lung cancers

New findings suggest that the procedure offers effective local control and a favorable safety profile for patients with medically inoperable stage 1A non-small cell lung cancer.

Department of energy partners to bolster domestic radioisotope supply

Gadolinium-153, or Gd-153, is routinely used to calibrate nuclear imaging equipment. It has been in short supply since 2023 when global distribution of the radioisotope came to a halt.

Novartis sued for allegedly leaking data on breast cancer patient to Google, Contentsquare

In a lawsuit seeking class action status, a woman identified as “P.M.” said she began using the website for Kisqali, a Novartis breast cancer treatment, in late 2024 shortly after being issued a prescription. Unbeknownst to her, sensitive data she shared when seeking a discount may have been shared with advertisers.

intrasaccular flow disruptor coronary aneurysm

Cardiologists use endovascular device for brain aneurysms to treat high-risk heart patients

A multidisciplinary research team has found a new use for a reliable medical device. Multiple heart patients have already benefited for the group’s outside-the-box thinking.

$Radiologist Michael Morris, MD, radiologist and director of cardiac CT and MRI at Banner Health, explains how cardiac radiology imaging is moving toward expanded use of fractional flow reserve CT (FFR-CT) and artificial intelligence analysis of coronary CT angiography (CCTA) exams as a standard of care. He spoke to Radiology Business during RSNA 2025.$

Radiology embraces FFR-CT and AI plaque analysis as cardiac imaging evolves

The specialty is moving toward expanded use of fractional flow reserve CT and AI analysis of coronary CT angiography exams as a standard of care.

When heart patients can’t wait: Urgent TAVR with self-expanding vs. balloon-expandable valves

The high-risk patients who require urgent or emergent TAVR are often excluded from major clinical trials. To learn more about this population, researchers explored data from nearly 600 patients treated at high-volume facilities.

Cardiologist makes history with first commercial implant of new pacing lead for LBBAP

The first FDA-approved pacing lead specifically developed for LBBAP is now being implanted throughout the United States.

Abbott makes IVL move as FDA approves new clinical trial

Abbott has received an investigational device exemption from the FDA for a new clinical trial evaluating the safety and effectiveness of using its coronary IVL technology. The trial is expected to enroll up to 335 U.S. patients.

Imaging may be misleading when determining the success of cancer treatment

A new analysis calls into question the use of imaging alone to determine the efficacy of ablative radiation therapy.

Video of Steven Bolling, MD, professor of cardiac surgery, University of Michigan, explaining trends in tricuspid valve repair and replacement at CRT 2025.

Key trends in transcatheter tricuspid valve interventions

Steven Bolling, MD, noted that tricuspid treatments have been linked to consistent benefits in terms of quality of life. However, he said, finding clear improvements in clinical outcomes has been more challenging.

New drug shows early potential to treat aortic stenosis in some patients without TAVR, SAVR

The drug in question, ataciguat, could help heart patients avoid aortic valve replacement—or at least put it off until later in life.

Around the web

Health Exec

Moral distress in physicians: New study measures prevalence, offers interventions